BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36209761)

  • 1. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
    GBD 2019 Healthcare Access and Quality Collaborators
    Lancet Glob Health; 2022 Dec; 10(12):e1715-e1743. PubMed ID: 36209761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    GBD 2016 Healthcare Access and Quality Collaborators
    Lancet; 2018 Jun; 391(10136):2236-2271. PubMed ID: 29893224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.
    ;
    Lancet; 2017 Jul; 390(10091):231-266. PubMed ID: 28528753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Mortality Collaborators
    Lancet; 2017 Sep; 390(10100):1084-1150. PubMed ID: 28919115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Child Mortality Collaborators
    Lancet; 2016 Oct; 388(10053):1725-1774. PubMed ID: 27733285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
    Al-Hajj S; Farran S; Sibai AM; Hamadeh RR; Rahimi-Movaghar V; Al-Raddadi RM; Sadeghian F; Ghodsi Z; Alhajyaseeh W; Rmeileh NMA; Mokdad AH;
    Lancet Healthy Longev; 2022 Apr; 3(4):e253-e262. PubMed ID: 35515813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
    GBD 2019 Diabetes Mortality Collaborators
    Lancet Diabetes Endocrinol; 2022 Mar; 10(3):177-192. PubMed ID: 35143780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016.
    GBD 2016 SDG Collaborators
    Lancet; 2017 Sep; 390(10100):1423-1459. PubMed ID: 28916366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    GBD 2019 Child and Adolescent Communicable Disease Collaborators
    Lancet; 2023 Jul; 402(10398):313-335. PubMed ID: 37393924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 SDG Collaborators
    Lancet; 2018 Nov; 392(10159):2091-2138. PubMed ID: 30496107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Universal Health Coverage Collaborators
    Lancet; 2020 Oct; 396(10258):1250-1284. PubMed ID: 32861314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Epilepsy Collaborators
    Lancet Neurol; 2019 Apr; 18(4):357-375. PubMed ID: 30773428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15-39 years in 204 countries/territories, 1990-2019: a systematic analysis of Global Burden of Disease Study 2019.
    Sun J; Qiao Y; Zhao M; Magnussen CG; Xi B
    BMC Med; 2023 Jun; 21(1):222. PubMed ID: 37365627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Respiratory Tract Cancers Collaborators
    Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.